Upgrade to SI Premium - Free Trial

BTIG Reiterates Buy Rating on MiniMed Group (MMED)

March 31, 2026 5:47 AM
BTIG analyst Marie Thibault reiterated a Buy rating and $25.00 price target on MiniMed Group (NASDAQ: MMED).The analyst comments "MiniMed ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles